Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Due to system maintenance, login and edit functionaility is currently unavailable

Glenn J. Bubley, M.D.

Co-Author

This page shows the publications co-authored by Glenn Bubley and Rupal Bhatt.
Connection Strength

1.108
  1. The challenge of herbal therapies for prostate cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7581-2.
    View in: PubMed
    Score: 0.395
  2. Hypoxia-inducible factor-2alpha: effect on radiation sensitivity and differential regulation by an mTOR inhibitor. BJU Int. 2008 Aug; 102(3):358-63.
    View in: PubMed
    Score: 0.377
  3. Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. J Clin Invest. 2020 06 01; 130(6):3287-3298.
    View in: PubMed
    Score: 0.219
  4. Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance. Clin Cancer Res. 2021 07 01; 27(13):3610-3619.
    View in: PubMed
    Score: 0.058
  5. Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1416-1422.
    View in: PubMed
    Score: 0.058
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.